[144] NuSkin Enterprises, Inc. SEC Filing

Rhea-AI Filing Summary

NuSkin Enterprises, Inc. (NUS) Form 144 shows a proposed sale of 6,489 Class A shares through William Blair in Chicago, to be executed approximately on 09/04/2025 on the NYSE. The filing lists an aggregate market value of $77,868.00 and reports 49,497,715 Class A shares outstanding for the issuer.

The 6,489 shares were acquired from the issuer as compensation across annual grant dates: 04/30/2021 (422 shares), 04/30/2022 (2,467), 04/30/2023 (3,179) and 04/30/2024 (421), with matching payment dates. The filer reports no securities sold in the past three months and includes the standard attestation regarding absence of undisclosed material adverse information.

Positive

• Full disclosure of planned sale including broker, share count, aggregate market value, planned sale date, and exchange
• Acquisition history provided showing the shares were received as compensation with specific dates and amounts
• No securities sold in the past three months, reducing concerns about immediate prior insider selling activity

Negative

• None.

Insights

Insider Transactions Analyst

TL;DR: A routine disclosure of an insider sale of compensated shares through a broker; no recent sales reported.

The filing documents a small, planned sale of 6,489 Class A shares acquired as compensation over 2021–2024 and routed through William Blair. The disclosure includes aggregate market value and outstanding share count, enabling transparency of the proposed sale. The absence of sales in the prior three months and the representation regarding material nonpublic information suggest this is a routine liquidity event rather than a reaction to new company-specific developments.

Corporate Compliance Officer

TL;DR: Form 144 appears complete for Rule 144 notice purposes and contains the required attestations.

The document lists acquisition dates, nature of acquisition (compensation), payment dates, broker details, planned sale date, and market value; it also includes the mandatory signature attestation concerning material information. From a compliance standpoint the form contains the core elements required for a proposed Rule 144 sale notice and notes no aggregated sales in the recent three-month window.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	William Blair 150 N Riverside PLZ CHicago IL 60606	6489	77868.00	49497715	09/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	04/30/2021	Payment	Issuer			422	04/30/2021	Compensation
Class A	04/30/2022	Payment	Issuer			2467	04/30/2022	Compensation
Class A	04/30/2023	Payment	Issuer			3179	04/30/2023	Compensation
Class A	04/30/2024	Payment	Issuer			421	04/30/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What Class A securities is NUS proposing to sell in this Form 144?

The filing proposes the sale of 6,489 Class A shares of NuSkin Enterprises.

When is the proposed sale date and through which broker will the NUS shares be sold?

The approximate sale date is 09/04/2025 and the broker listed is William Blair (150 N Riverside Plaza, Chicago, IL).

What is the aggregate market value and how many Class A shares are outstanding for NUS?

The aggregate market value is reported as $77,868.00 and the filing lists 49,497,715 Class A shares outstanding.

How were the 6,489 shares acquired according to the Form 144?

All shares were acquired from the issuer as compensation on the dates 04/30/2021, 04/30/2022, 04/30/2023, and 04/30/2024.

Did the filer sell any NUS securities in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.